Edwards Lifesciences Corporation EW
86.29
0.56
0.65%
as of 25 Sep
- Market cap
- $49.4B
- P/E
- 49.6×
Follow EW
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years
Edwards Lifesciences Corporation (EW) EBITDA
Edwards Lifesciences Corporation's EBITDA for fiscal 2025 was $1.4B, down 7.37% from $1.5B in fiscal 2024. Over the twelve months to 30 June 2026 it was $1.6B. Over the past ten years it has ranged from $708.5M (fiscal 2015) to $1.8B (fiscal 2021); the current reading is higher than 64% of that period. Edwards Lifesciences Corporation ranks 10th of 147 Medical Devices companies by EBITDA.
EBITDA, annual
Annual
| Period | EBITDA | Change |
|---|---|---|
| FY2025 | $1.4B | (7.37%) |
| FY2024 | $1.5B | 5.51% |
| FY2023 | $1.5B | (11.25%) |
| FY2022 | $1.6B | (10.25%) |
| FY2021 | $1.8B | 81.64% |
| FY2020 | $1.0B | (18.71%) |
| FY2019 | $1.2B | 49.72% |
| FY2018 | $825.6M | (29.51%) |
| FY2017 | $1.2B | 36.99% |
| FY2016 | $855.0M | 20.68% |
Quarterly
| Period | EBITDA | Change |
|---|---|---|
| Jun 2026 | $555.9M | 7.21% |
| Mar 2026 | $518.5M | 167.54% |
| Dec 2025 | $193.8M | (44.04%) |
| Sep 2025 | $346.3M | (22.92%) |
| 42 more quarters | Free account |
Against its own ten years
Low $708.5M
High $1.8B
Ten-year median
$1.2B
Current reading's percentile
64
EBITDA against peers
| Company | EBITDA |
|---|---|
| MDT Medtronic PLC compare | $9.7B |
| SYK Stryker Corporation compare | $6.8B |
| BSX Boston Scientific Corporation compare | $5.6B |
| PHG Koninklijke Philips N.V. compare | $3.4B |
| GEHC GE HealthCare Technologies Inc. compare | $3.3B |
| ZBH Zimmer Biomet Holdings, Inc. compare | $2.3B |
| STE STERIS plc compare | $1.6B |
| EW Edwards Lifesciences Corporation | $1.6B |
| DXCM DexCom, Inc. compare | $1.4B |
What EBITDA is
EBITDA shows what a company earns from its operations before interest, taxes and the non-cash charges for depreciation and amortization.
Reported line item
More on EW
- Revenue
- Net income
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement